{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T16:30:24Z","timestamp":1789576224928,"version":"build-2803163510"},"reference-count":152,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 81873444"],"award-info":[{"award-number":["No. 81873444"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 82070213"],"award-info":[{"award-number":["No. 82070213"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 82370196"],"award-info":[{"award-number":["No. 82370196"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Cell Transplant"],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:p>B-cell lymphoma, the most common subtype of non-Hodgkin lymphoma, presents major therapeutic challenges due to molecular heterogeneity and high relapse rates. While autologous hematopoietic stem cell transplantation (ASCT) has been a cornerstone for relapsed\/refractory (R\/R) B-cell lymphoma, its efficacy is often compromised by minimal residual disease (MRD) persistence and an immunosuppressive tumor microenvironment. Chimeric antigen receptor (CAR)-T cell therapy has transformed treatment paradigms but faces limited long-term durability due to antigen escape and T-cell exhaustion. The integration of ASCT with CAR-T therapy may offer a complementary approach to address these limitations, leveraging ASCT-induced immune reconstitution to enhance CAR-T-cell persistence and reprogram the tumor milieu. Emerging clinical evidence supports this approach, indicating improved disease control and progression-free survival. Although preliminary clinical outcomes are encouraging, unresolved challenges persist, particularly in terms of cumulative toxicity, optimal therapeutic sequencing, CAR-T-cell longevity, and financial feasibility associated with these advanced therapies. This review provides a comprehensive overview of mechanistic synergies between ASCT and CAR-T therapy, critically evaluates emerging clinical evidence on treatment sequencing, and explores innovative strategies to increase safety, efficacy, and accessibility.<\/jats:p>","DOI":"10.1177\/09636897251379571","type":"journal-article","created":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T07:17:44Z","timestamp":1761376664000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":2,"title":["Autologous stem cell transplantation meets CAR-T therapy: A synergistic strategy for B-cell lymphoma"],"prefix":"10.1177","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-4633-3167","authenticated-orcid":false,"given":"Xumeng","family":"Zhao","sequence":"first","affiliation":[{"name":"Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaying","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojian","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,10,25]]},"reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-022-01764-1"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-021-01134-x"},{"issue":"3","key":"e_1_3_2_4_2","article-title":"How to treat diffuse large B-cell lymphoma: oncologic and cardiovascular considerations","volume":"5","author":"Thiruvengadam SK","year":"2023","unstructured":"Thiruvengadam SK, Herrera AF, Rhee JW. How to treat diffuse large B-cell lymphoma: oncologic and cardiovascular considerations. JACC CardioOncol. 2023;5(3):281\u201391.","journal-title":"JACC CardioOncol"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12860"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21228553"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13020214"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0016-8"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21551"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2027612"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.modpat.2022.100007"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12237376"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-11-764332"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13071929"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011795"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S326632"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1186\/s40164-023-00432-z"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022018730"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022015478"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2116133"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1397186"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021011994"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14081917"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/hem3.130"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.3390\/cells12141858"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.currproblcancer.2021.100826"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMe2118899"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.3390\/cells13181596"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.780442"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-18-0466"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1177\/20406207241237594"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022015789"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.36401\/JIPO-21-2"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2021.10.010"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.4149\/neo_2020_200303N224"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021005602"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16111987"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2016.213"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2022007706"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2022.06.015"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-17-3561"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.102318"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2017.1369061"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019000784"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-020-07561-2"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-023-00820-y"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25621"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000185"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2019.3869"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcyt.2023.03.005"},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2015.162"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-021-01044-y"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2021.101085"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-20-1457"},{"issue":"4","key":"e_1_3_2_55_2","article-title":"Lenalidomide overcomes the resistance to third-generation CD19-CAR-T cell therapy in preclinical models of diffuse large B-cell lymphoma","volume":"46","author":"Jin Z","year":"2023","unstructured":"Jin Z, Xiang R, Qing K, Li D, Liu Z, Li X, Zhu H, Zhang Y, Wang L, Xue K, Liu H, et al Lenalidomide overcomes the resistance to third-generation CD19-CAR-T cell therapy in preclinical models of diffuse large B-cell lymphoma. Cell Oncol (Dordr). 2023;46(4):1143\u201357.","journal-title":"Cell Oncol (Dordr)"},{"key":"e_1_3_2_56_2","doi-asserted-by":"publisher","DOI":"10.3390\/cells13060555"},{"key":"e_1_3_2_57_2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14215276"},{"key":"e_1_3_2_58_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-22-0164"},{"key":"e_1_3_2_59_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022016226"},{"key":"e_1_3_2_60_2","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023011287"},{"key":"e_1_3_2_61_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e38023"},{"key":"e_1_3_2_62_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-019-0657-3"},{"key":"e_1_3_2_63_2","doi-asserted-by":"publisher","DOI":"10.21037\/tcr-20-72"},{"key":"e_1_3_2_64_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22168706"},{"key":"e_1_3_2_65_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-021-01285-3"},{"key":"e_1_3_2_66_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-021-02850-6"},{"key":"e_1_3_2_67_2","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-20-0675"},{"key":"e_1_3_2_68_2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.01350"},{"key":"e_1_3_2_69_2","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1743"},{"key":"e_1_3_2_70_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020009432"},{"issue":"9","key":"e_1_3_2_71_2","article-title":"CD70-targeting CAR-T cells have potential activity against CD19-negative B-cell lymphoma","volume":"41","author":"Deng W","year":"2021","unstructured":"Deng W, Chen P, Lei W, Xu Y, Xu N, Pu JJ, Liang A, Qian W. CD70-targeting CAR-T cells have potential activity against CD19-negative B-cell lymphoma. Cancer Commun (Lond). 2021;41(9):925\u201329.","journal-title":"Cancer Commun (Lond)"},{"key":"e_1_3_2_72_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101421"},{"key":"e_1_3_2_73_2","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-001150"},{"issue":"20","key":"e_1_3_2_74_2","article-title":"Dual targeting of CD19 and CD22 with bicistronic CAR-T cells in patients with relapsed\/refractory large B-cell lymphoma","volume":"141","author":"Roddie C","year":"2023","unstructured":"Roddie C, Lekakis LJ, Marzolini MAV, Ramakrishnan A, Zhang Y, Hu Y, Peddareddigari VGR, Khokhar N, Chen R, Basilico S, Raymond M, et al Dual targeting of CD19 and CD22 with bicistronic CAR-T cells in patients with relapsed\/refractory large B-cell lymphoma. Blood. 2023;141(20):2470\u201382.","journal-title":"Blood"},{"key":"e_1_3_2_75_2","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000736"},{"key":"e_1_3_2_76_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-019-0737-3"},{"key":"e_1_3_2_77_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-020-01011-z"},{"key":"e_1_3_2_78_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2019.05.065"},{"key":"e_1_3_2_79_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1910607"},{"key":"e_1_3_2_80_2","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.815679"},{"key":"e_1_3_2_81_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-021-01838-z"},{"key":"e_1_3_2_82_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-020-0892-7"},{"key":"e_1_3_2_83_2","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2021.280009"},{"key":"e_1_3_2_84_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01659-2"},{"key":"e_1_3_2_85_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-12-686725"},{"key":"e_1_3_2_86_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2021.08.012"},{"key":"e_1_3_2_87_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keq414"},{"key":"e_1_3_2_88_2","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000295"},{"key":"e_1_3_2_89_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01109"},{"key":"e_1_3_2_90_2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13061229"},{"key":"e_1_3_2_91_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1186383"},{"key":"e_1_3_2_92_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1121565"},{"key":"e_1_3_2_93_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2022.07.015"},{"key":"e_1_3_2_94_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1041177"},{"key":"e_1_3_2_95_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-024-01193-6"},{"key":"e_1_3_2_96_2","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2021.12879"},{"key":"e_1_3_2_97_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20191712"},{"key":"e_1_3_2_98_2","first-page":"53","article-title":"Resetting the immune system with immunoablation and autologous haematopoietic stem cell transplantation in autoimmune diseases","volume":"34","author":"Alexander T","year":"2016","unstructured":"Alexander T, Arnold R, Hiepe F, Radbruch A. Resetting the immune system with immunoablation and autologous haematopoietic stem cell transplantation in autoimmune diseases. Clin Exp Rheumatol. 2016;34:53\u201357.","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_3_2_99_2","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/2900310"},{"key":"e_1_3_2_100_2","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019000593"},{"key":"e_1_3_2_101_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-021-00523-2"},{"key":"e_1_3_2_102_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-024-01084-w"},{"key":"e_1_3_2_103_2","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-008857"},{"key":"e_1_3_2_104_2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16091722"},{"key":"e_1_3_2_105_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-00924-0"},{"key":"e_1_3_2_106_2","doi-asserted-by":"publisher","DOI":"10.2217\/imt-2020-0075"},{"key":"e_1_3_2_107_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2018883421"},{"key":"e_1_3_2_108_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1307242"},{"key":"e_1_3_2_109_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1098815"},{"key":"e_1_3_2_110_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1127868"},{"key":"e_1_3_2_111_2","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.17121"},{"key":"e_1_3_2_112_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2020.04.025"},{"key":"e_1_3_2_113_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2022.10.026"},{"key":"e_1_3_2_114_2","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2022.281242"},{"key":"e_1_3_2_115_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-022-01903-3"},{"key":"e_1_3_2_116_2","doi-asserted-by":"publisher","DOI":"10.21037\/tcr-22-174"},{"key":"e_1_3_2_117_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-019-0674-2"},{"key":"e_1_3_2_118_2","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2022009025"},{"key":"e_1_3_2_119_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-018-1204-6"},{"key":"e_1_3_2_120_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2023.05.011"},{"key":"e_1_3_2_121_2","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2023.1305657"},{"issue":"10","key":"e_1_3_2_122_2","article-title":"CD19\/CD22 dual-targeting chimeric antigen receptor T-cell therapy bridging to allogeneic haematopoietic stem cell transplantation for B-cell acute lymphoblastic leukaemia delays platelet recovery and increases risks of cytomegalovirus and Epstein-Barr virus viremia after transplantation","volume":"13","author":"Li S","year":"2023","unstructured":"Li S, Ge J, Zhou S, Zhu W, Han Y, Chen S, Xue S, Wang Y, Qiu H, Wu X, Wu D. CD19\/CD22 dual-targeting chimeric antigen receptor T-cell therapy bridging to allogeneic haematopoietic stem cell transplantation for B-cell acute lymphoblastic leukaemia delays platelet recovery and increases risks of cytomegalovirus and Epstein-Barr virus viremia after transplantation. Clin Transl Med. 2023;13(10):e1459.","journal-title":"Clin Transl Med"},{"key":"e_1_3_2_123_2","doi-asserted-by":"publisher","DOI":"10.3390\/v16040498"},{"key":"e_1_3_2_124_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26767"},{"issue":"7","key":"e_1_3_2_125_2","article-title":"Autologous stem cell transplant in fit patients with refractory or early relapsed diffuse large B-cell lymphoma that responded to salvage chemotherapy","volume":"109","author":"Tun AM","year":"2024","unstructured":"Tun AM, Wang Y, Maliske S, Micallef I, Inwards DJ, Habermann TM, Porrata L, Paludo J, Bisneto JV, Rosenthal A, Kharfan-Dabaja MA, et al Autologous stem cell transplant in fit patients with refractory or early relapsed diffuse large B-cell lymphoma that responded to salvage chemotherapy. Haematologica. 2024;109(7):2186\u201395.","journal-title":"Haematologica"},{"key":"e_1_3_2_126_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26293"},{"key":"e_1_3_2_127_2","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021005788"},{"key":"e_1_3_2_128_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11899-021-00610-y"},{"key":"e_1_3_2_129_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0317439"},{"key":"e_1_3_2_130_2","volume-title":"Statpearls [Internet]","author":"Shaikh S","year":"2023","unstructured":"Shaikh S, Shaikh H. CART cell therapy toxicity. In: Statpearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023."},{"key":"e_1_3_2_131_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1422591"},{"key":"e_1_3_2_132_2","doi-asserted-by":"publisher","DOI":"10.1182\/hematology.2023000436"},{"key":"e_1_3_2_133_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01973"},{"key":"e_1_3_2_134_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-025-01538-5"},{"key":"e_1_3_2_135_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.914959"},{"key":"e_1_3_2_136_2","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-003847"},{"key":"e_1_3_2_137_2","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023011027"},{"key":"e_1_3_2_138_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.577027"},{"key":"e_1_3_2_139_2","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020002328"},{"key":"e_1_3_2_140_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02404-6"},{"key":"e_1_3_2_141_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.904497"},{"key":"e_1_3_2_142_2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16101881"},{"key":"e_1_3_2_143_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1430070"},{"key":"e_1_3_2_144_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-186603"},{"key":"e_1_3_2_145_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-022-04881-0"},{"key":"e_1_3_2_146_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmmed.2024.1310002"},{"key":"e_1_3_2_147_2","doi-asserted-by":"publisher","DOI":"10.3390\/cells13020146"},{"key":"e_1_3_2_148_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1557157"},{"key":"e_1_3_2_149_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1585556"},{"key":"e_1_3_2_150_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022016204"},{"key":"e_1_3_2_151_2","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2024015157"},{"key":"e_1_3_2_152_2","doi-asserted-by":"publisher","DOI":"10.7326\/M22-2276"},{"key":"e_1_3_2_153_2","doi-asserted-by":"publisher","DOI":"10.46989\/001c.115793"}],"container-title":["Cell Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/09636897251379571","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/09636897251379571","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/09636897251379571","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T15:36:17Z","timestamp":1777390577000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/09636897251379571"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":152,"alternative-id":["10.1177\/09636897251379571"],"URL":"https:\/\/doi.org\/10.1177\/09636897251379571","relation":{},"ISSN":["0963-6897","1555-3892"],"issn-type":[{"value":"0963-6897","type":"print"},{"value":"1555-3892","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10]]},"article-number":"09636897251379571"}}